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ABBREVIATIONS LIST  22 
 23 
ALI = Air-Liquid Interface 24 
BEGM = Bronchial Epithelial Growth Media 25 
CBF = Cilia Beat Frequency 26 
CFBE = Cystic Fibrosis Bronchial Epithelial 27 
CRCs = Conditionally Reprogrammed Cells 28 
DMEM = Dulbecco's Modified Eagle Medium 29 
GFP = Green Fluorescent Protein 30 
HBE = Human Bronchial Epithelial 31 
hESCs = human Embryonic Stem Cells 32 
hTERT = human Telomerase Reverse Transcriptase 33 
iPSCs = induced Pluripotent Stem Cells 34 
Isc = short circuit current 35 
NHBE = Normal Human Bronchial Epithelial 36 
ODA = Outer Dynein Arms 37 
PBS = Phosphate Buffered Saline 38 
PCD = Primary Ciliary Dyskinesia 39 
ROCK = Rho-associated protein kinase  40 
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ABSTRACT 41 
Air-liquid interface (ALI) culture of primary airway epithelial cells enables mucociliary 42 
differentiation providing an in vitro model of the human airway but their proliferative 43 
potential is limited. To extend proliferation, these cells were previously transduced 44 
with viral oncogenes or mouse Bmi-1 + hTERT but the resultant cell lines did not 45 
undergo mucociliary differentiation. We hypothesised that use of human BMI-1 alone 46 
would increase the proliferative potential of bronchial epithelial cells while retaining 47 
their mucociliary differentiation potential. CF and non-CF bronchial epithelial cells 48 
were transduced by lentivirus with BMI-1 then their morphology, replication kinetics 49 
and karyotype were assessed. When differentiated at ALI, mucin production, ciliary 50 
function and transepithelial electrophysiology were measured. Finally, shRNA 51 
knockdown of DNAH5 in BMI-1 cells was used to model primary ciliary dyskinesia 52 
(PCD).  BMI-1 transduced basal cells showed normal cell morphology, karyotype 53 
and doubling times despite extensive passaging. The cell lines underwent 54 
mucociliary differentiation when cultured at ALI with abundant ciliation and 55 
production of the gel-forming mucins MUC5AC and MUC5B evident. Cilia displayed 56 
a normal beat frequency and 9+2 ultrastructure. Electrophysiological characteristics 57 
of BMI-1 transduced cells were similar to un-transduced cells. shRNA knockdown of 58 
DNAH5 in BMI-1 cells produced immotile cilia and absence of DNAH5 in the ciliary 59 
axoneme as seen in cells from patients with PCD. BMI-1 delayed senescence in 60 
bronchial epithelial cells, increasing their proliferative potential but maintaining 61 
mucociliary differentiation at ALI. We have shown these cells are amenable to 62 
genetic manipulation and can be used to produce novel disease models for research 63 
and dissemination. 64 
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INTRODUCTION 67 
The ciliated epithelium lining the airways provides the first line of defence to inhaled 68 
pathogens and particles and plays a crucial role in many respiratory diseases. It is possible 69 
to remove respiratory epithelial cells from the nose or upper airways of donors by brushing 70 
and culture them in the laboratory on collagen-coated, semi-permeable membranes. The 71 
progenitor basal epithelial cells from the brushings cultured at Air-Liquid Interface (ALI) 72 
differentiate into a fully ciliated, pseudostratified epithelium closely resembling that found in 73 
the airway (3).  74 
If cells are obtained from a donor with a lung disease, e.g., cystic fibrosis, primary ciliary 75 
dyskinesia (PCD), asthma and chronic obstructive pulmonary disease, these ALI cultures 76 
provide a surrogate model of the diseased lung for research into pathogenic mechanisms 77 
and for the development of new therapeutics(9, 14, 16). However, basal epithelial cells can 78 
only be passaged 2-3 times before they lose their proliferation and differentiation potential 79 
(6, 18). Thus, to establish the wider use of basal cells in ALI epithelial culture models, 80 
methods are required that enable basal cells to be cultured for longer, genetically 81 
engineered, expanded and stored easily prior to differentiation on ALI cultures. Such cells 82 
would also overcome ethical issues related to repeated brushing of volunteers. 83 
Recent approaches to extend the utility of primary, basal epithelial cells involved culturing 84 
them with rho-associated protein kinase (ROCK) inhibitors on a layer of irradiated feeder 85 
cells to provide cell-derived growth factors (18, 27). The requirement for irradiated feeder 86 
cells makes the maintenance of basal cell cultures complex and time-consuming, difficult to 87 
scale up and may limit the use of this approach to specialist laboratories. Alternatively, 88 
induced pluripotent stem cells (iPSCs) and embryonic stem cells (hESCs) were differentiated 89 
into mature respiratory epithelial cells and used to generate a pseudostratified epithelium 90 
expressing CFTR (30).  However, the process takes several weeks and often the resulting 91 
cultures are not suitable for disease modelling as they are contaminated with endodermal 92 
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cell types (31) and often present with karyotypic anomalies which may confound drug 93 
screening efforts.  94 
Extended proliferative potential of primary human bronchial epithelial (HBE) cells 95 
was described by transduction of basal cells with the mouse polycomb complex 96 
protein Bmi-1 and human telomerase reverse transcriptase (hTERT) (6). Unlike cells 97 
transformed with viral oncogenes, Bmi-1+hTERT cell lines had no chromosomal 98 
abnormalities and produced a pseudostratified epithelium on ALI but gave only 99 
sparse ciliogenesis. This limited differentiation capacity may be explained by reports 100 
that hTERT, following long-term growth in culture, up-regulates expression of the 101 
potent mitogen c-Myc, so promoting entry into the cell cycle (21) thereby impeding 102 
ciliogenesis.  103 
We hypothesised that BMI-1 transduction alone may overcome these issues 104 
observed with Bmi-1+hTERT, to produce basal cells with the potential for extended 105 
proliferation that retain their differentiation capacity on ALI. In this study, BMI-1 106 
transduced primary basal epithelial cells from CF and healthy donors were 107 
investigated for their morphology, growth characteristics and karyotype. We also 108 
assessed the cells mucociliary differentiation potential at ALI along with their Na+ and 109 
Cl- transport properties in Ussing chamber studies.  We then demonstrate their use 110 
for the production of novel engineered disease models by shRNA knockdown of 111 
DNAH5, a gene associated with PCD, a ciliopathy with significant lung pathology 112 
resulting from abnormal mucociliary clearance. BMI-1 transduction offers a facile 113 
method to greatly extend the utility of basal epithelial cells for translational and basic 114 
research. 115 
  116 
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MATERIALS & METHODS 117 
Materials  118 
Primary antibodies used in this study can be found in Table 1. Secondary antibodies 119 
for immunofluorescence were anti-IgG antibodies conjugated with AlexaFluor dyes 120 
(Invitrogen, Life Technologies). Secondary antibodies for Western blots were 121 
horseradish peroxidase-conjugated (HRP-conjugated) anti-IgG antibodies (Dako, 122 
Agilent Technologies). 123 
Collagen Coating 124 
Tissue culture flasks and transwells were coated for 1 hour at room temperature with 125 
1% (v/v) solution of a 3mg/mL bovine collagen solution (PureCol; Advanced 126 
Biomatrix) in phosphate buffered saline (PBS), then washed with distilled water and 127 
air-dried. 128 
Cell Culture 129 
HEK293T cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) 130 
supplemented with 10% (v/v) foetal bovine serum. Normal human bronchial epithelial 131 
(NHBE) cells, cystic fibrosis human bronchial epithelial cells (CFBE) cells were 132 
grown on collagen-coated plastic in bronchial epithelial growth media (BEGM; 133 
Lonza). All cells were grown at 37oC and 5% CO2. NHBE and CFBE cells were 134 
purchased from Lonza and Epithelix SàRL.  135 
Lentivirus Production and Transduction 136 
Full-length human BMI-1 cDNA was PCR cloned from pHR-EF1α-BMI1-IRES-GFP 137 
plasmid(20) with XhoI and BamHI sites added and TOPO cloned into pCR4 TOPO 138 
vector before being subcloned into pLVX-Puro vector digested with XhoI and BamHI. 139 
Lentivirus was produced as previously described(20), concentrated by centrifugation 140 
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at 4,500 x g for 18 hours at 4oC, re-suspended in OptiMem and added to cell media 141 
to transduce NHBE and CFBE cells (Lonza) at passage 2.  142 
Doubling Time Analysis 143 
NHBE and NHBE BMI-1 cells at varying passage numbers were seeded at densities 144 
of 30,000 cells per well onto collagen-coated 12-well plates. Cells were detached 145 
using trypsin-EDTA following 1-4 days in culture and total cell numbers per well were 146 
counted using a haemocytometer. An online calculator was used to calculate the 147 
doubling time (Roth V. 2006 Doubling Time Computing, Available from: 148 
http://www.doubling-time.com/compute.php). Doubling times were calculated using 149 
the formula;  150 
݀݋ݑܾ݈݅݊݃ ݐ݅݉݁ =
݀ݑݎܽݐ݅݋݊ × log(2)
log(݂݈݅݊ܽ ݈݈ܿ݁ ܿ݋ݑ݊ݐ) − log(݅݊݅ݐ݈݅ܽ ݈݈ܿ݁ ܿ݋ݑ݊ݐ) 
Where cell count values were mean cell count of 3 independent wells.  151 
Western Blotting 152 
Cells were lysed with Cell Extraction Buffer (Life Technologies), boiled in the 153 
presence of NuPage LDS Sample Buffer (Life Technologies) and loaded onto 154 
NuPage Novex 4-12% Bis-Tris gels (Life Technologies). Electrophoresis and protein 155 
transfer onto Immobilon-P polyvinylidene fluoride membranes were performed using 156 
standard protocols. Antibodies against BMI-1, p16Ink4a and GAPDH and 157 
appropriate HRP-conjugated secondary antibodies were used for probing with bands 158 
visualised using Pierce ECL Western Blotting Substrate (Life Technologies, Paisley, 159 
UK) and a UVIchemi chemiluminescence imaging system (UVItec).  160 
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Air-liquid Interface (ALI) Culture 161 
Cells grown to ~80% confluence in T75 flasks were trypsinised, seeded at a density 162 
of 900,000 cells/cm2 on Transwell inserts (Corning) and grown at an ALI as 163 
previously described(8). Cell were maintained at an ALI for 4 weeks before analyses 164 
were performed. 165 
Quantitative Reverse Transcription PCR (qRT-PCR) 166 
Unless indicated, all reagents for qRT-PCR were obtained from ThermoFisher. Total 167 
RNA was harvested from cells using RNeasy Mini Kit (Qiagen) and potential DNA 168 
impurities digested using DNase I enzyme (TURBO DNA-free kit). Purified RNA was 169 
reverse transcribed with 2.5U/µL murine leukaemia virus (MuLV) reverse 170 
transcriptase at 42oC for 1 hour in a reaction containing 1x GeneAmp PCR Gold 171 
Buffer, 1mM each dNTP, 5µM random hexamers, 5mM MgCl2 and 1U/µL RNase 172 
inhibitor.  The resulting cDNA was used in a qPCR reaction containing 1x Platinum 173 
Quantitative PCR SuperMix-UDG w/ROX and 1x TaqMan Gene Expression Assay 174 
primer/probe set (GAPDH primer/probe set Hs99999905_m1; DNAH5 primer/probe 175 
set Hs00292485_m1). The PCR reaction cycles used were 50oC for 2 minutes, 95oC 176 
for 10 minutes, 40 cycles of 95oC for 15 seconds and 60oC for 1 minute on an ABI 177 
PRISM 7000 Sequence Detection System (Applied Biosystems). Fluorescence data 178 
was collected at the end of each 60oC reaction and relative expression levels 179 
calculated using the delta-delta Ct (2- ΔΔCt) method(19). 180 
Immunofluorescence Staining and Confocal Microscopy 181 
Cells were fixed with 4% PFA for 10 minutes at room temperature, washed with PBS 182 
and permeabilised with PBS-Triton (PBS 0.1% (v/v) Triton-X100) for 10 minutes at 183 
room temperature before blocking, immunostaining and mounting on microscope 184 
slides as previously described(26). Images were obtained using an Inverted Zeiss 185 
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LSM 710 Confocal microscope with the appropriate excitation lasers selected for the 186 
dyes used.  187 
Fluorescence Microscopy 188 
Bright-field and fluorescence images were captured with a Nikon Digital Sight DS-189 
QiMC video camera attached to a Nikon Eclipse Ti-U inverted microscope. Videos 190 
and images were processed using NIS Elements AR software (Nikon, v4.00.12). 191 
TEM for Cilia Ultrastructure 192 
Ciliated cells cultured at an ALI were scraped and cells washed off with 200µL 193 
warmed BEBM. Cells were fixed by addition of 2mL of 2.5% glutaraldehyde and 194 
stored at 4oC for at least 24 hours prior to further processing as previously 195 
described(24). Assessment of cilia ultrastructure was undertaken blinded by Dr 196 
Amelia Shoemark, a member of the PCD diagnostic service team at the Royal 197 
Brompton & Harefield NHS Foundation Trust, UK. 198 
High-Speed Video Microscopy 199 
High-speed video was recorded using a MotionPro X4 high-speed motion camera 200 
attached to a Nikon Eclipse Ti-U inverted microscope built with an environmental 201 
chamber. Videos were recorded at a frame rate of 500fps using Motion Studio 202 
software (IDT Vision, v2.11) with cells maintained at 37oC.  203 
For cilia beat frequency (CBF) assessment, ALI cultures were washed twice with 204 
PBS to remove mucus that may have affected CBF. After washing, the cells were 205 
allowed to equilibrate at 37oC and 5% CO2 for 20 minutes before video recording. At 206 
least four independent cultures per donor line were videoed with five areas recorded 207 
per culture, i.e., at least 20 videos were captured per donor line. To minimise bias 208 
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videos were recorded from the top, bottom, left, right and centre region of each 209 
culture and cilia beat-frequency assessed using CiliaFA software(25). 210 
Electrophysiology Studies 211 
Cells were grown at ALI for 4 weeks on Snapwell membranes (Corning) to enable 212 
mucociliary differentiation. Snapwells were then mounted on Ussing chambers and 213 
short circuit current (Isc) was measured as previously described (32). Briefly, 214 
monolayers were mounted in Ussing chambers in physiological salt solution 215 
consisting of 117mM NaCl, 25mM NaHCO3, 4.7mM KCl, 1.2mM MgSO4, 1.2mM 216 
KH2PO4, 2.5mM CaCl2 and 11mM d-glucose. The solution was continuously 217 
circulated throughout the course of the experiment and maintained at 37oC whilst 218 
bubbled with 21% O2 + 5% CO2 premixed gas. Monolayers were first maintained 219 
under open-circuit conditions until transepithelial potential difference (Vt) and 220 
resistance stabilised. The cells were then short-circuited by clamping Vt at 0 mV 221 
using a DVC-4000 voltage/current clamp, and Isc was measured and recorded using 222 
a PowerLab computer interface. Every 30 seconds the preparations were returned to 223 
open-circuit conditions for 3 seconds so that the spontaneous Vt could be measured 224 
and trans-epithelial electrical resistance (TEER) calculated.  Drugs were circulated in 225 
physiological salt solution and added in the order of amiloride (10 μM, apical), 226 
forskolin (25 μM, apical and basolateral) and GlyH-101 (10 μM, apical).  227 
12 
 
RESULTS 228 
Characterisation of BMI-1 transduced cells in submerged culture 229 
Primary NHBE cells maintained in submerged cultures displayed a 230 
characteristic cobblestone appearance (Figure 1a) but by passage 3 cells became 231 
elongated in appearance (white arrow; Figure 1b) and squamous differentiation was 232 
evident (black arrow; Figure1b). In contrast, BMI-1 transduced NHBE cells (NHBE-233 
BMI-1) maintained their cobblestone appearance following extensive passaging, for 234 
example at passage 11 (Figure 1c) and passage 17 (Figure1d). However, squamous 235 
cells became evident following 25 passages (Figure 1e) after which the cells 236 
senesced, with no observable cell division for ten days. The cells maintained a 237 
normal diploid karyotype even at passage 23 (Figure 2). 238 
BMI-1 down-regulates expression of the pro-senescent protein p16Ink4A. NHBE 239 
cells transduced with BMI-1 had low levels of p16Ink4A protein and high levels of 240 
BMI-1 (Figure 3a). Levels of BMI-1 in untransduced NHBE cells declined with an 241 
increase in passaging whilst levels of p16Ink4A increased and were higher in 242 
senesced, untransduced NHBE cells at passage 6 while BMI-1 expression was not 243 
evident by Western blot (Figure 3a). 244 
SV40 large T-antigen or ROCK inhibition extends the replication potential of basal 245 
cells but alters the proliferation rate of the cells(4, 7, 12) therefore we assessed the 246 
doubling times of BMI-1 transduced cells at different passages (Figure 3b). We 247 
determined that untransduced cells at passage 2 had a doubling time of 1.18 days 248 
similar to BMI-1 transduced cells at passages 12 and 15 (doubling times of 1.25 and 249 
1.21 days respectively) although by passage 23 the doubling time had increased to 250 
1.49 days, consistent with observations of senescence at passage 25. 251 
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Differentiation of NHBE-BMI-1 Cells 252 
NHBE-BMI-1 basal cells were subsequently analysed for their differentiation 253 
potential when cultured at ALI. After 2 -3 weeks culture, both primary NHBE and 254 
NHBE-BMI-1 cells produced motile cilia (Video 1a and b respectively). NHBE-BMI-1 255 
cells maintained the ability to differentiate and produce cilia even at passage 15.  256 
To quantify cilia function, we assessed cilia beat frequency of both primary and BMI-257 
1 transduced NHBE and CFBE cells. Beating cilia from CFBE cells could not be 258 
detected, most likely due to the build-up of viscous mucus hindering cilia beating, 259 
until cultures were washed. As such, CFBE and NHBE cultures were washed twice 260 
prior to video recording and CBF analysis as detailed in the methods section.  261 
 CBF analysis of both primary and BMI-1 transduced NHBE and CFBE cells showed 262 
mean values within the normal range for respiratory cilia of 9-17Hz(25) (Figure 4a 263 
and b). Primary NHBE and NHBE-BMI-1 cells had a CBF of 16.7±0.2Hz and 264 
15.3±0.2Hz respectively (Figure 4a) and primary CFBE and CFBE-BMI-1 cells 265 
exhibited CBF values of 12.9±0.3Hz and 14.3±0.3Hz respectively.  266 
Further evidence of differentiation was demonstrated by immuno-detection, in 267 
NHBE-BMI-1 cells, of the tight junction protein occludin (Figure3c) and the mucins 268 
MUC5AC and MUC5B (Figure 4d, e). In addition, basal cells were present and 269 
indicated by p63 staining (Figure 4f) and BMI-1 protein was present in all nuclei 270 
(Figure 4g). The ciliary protein acetylated α-tubulin was also detected by 271 
immunostaining and highlighted abundant ciliation (Figure 4h). Further analysis of 272 
the cilia in differentiated NHBE-BMI-1 cells by TEM showed that they had a normal 273 
9+2 ultrastructure with both inner and outer dynein arms present (Figure 4i, Table 2 274 
and Table 3).   275 
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Electrophysiology studies  276 
Primary HBE cells grown on ALI develop a trans-epithelial electrical 277 
resistance (TEER) with ion transport properties that can be measured by mounting of 278 
cultured epithelia on Ussing chambers and addition of drugs that can activate or 279 
inhibit specific cell surface ion channels. Cultures of primary NHBE cells from two 280 
different donors showed baseline TEER values of 331.1±105.5Ω.cm2 and 281 
621.0±33.2Ω.cm2 (Table 4) and primary CFBE cells developed TEER of 282 
1307.9±36.6Ω.cm2. Similarly, BMI-1 transduced NHBE and CFBE cells developed 283 
high TEER when grown at an ALI (1268.4±78.4Ω.cm2 and 917.6±165.3Ω.cm2 284 
respectively; Table 4) demonstrating the cells retained their ability to form an 285 
electrically resistive epithelium.  286 
Short circuit current (Isc) analysis in Ussing chambers of NHBE and CFBE cells 287 
revealed that both primary NHBE cells and passage 13 NHBE-BM-1 cells cultured at 288 
ALI also had similar electrophysiology. Amiloride (10µM), an inhibitor of the epithelial 289 
Na+ channel ENaC reduced Isc in all cultures, although the amiloride-sensitive Isc was 290 
variable. Subsequent elevation of cellular cAMP with forskolin (25µM) increased Isc 291 
and this elevation was inhibited by the CFTR inhibitor Gly-H101 (10µM) (Figure 5 a, 292 
b). Thus, ENaC and CFTR-mediated ion transport was retained in NHBE-BMI-1 293 
cells.  Primary CFBE cells and passage 17 CFBE BMI-1 cells cultured at ALI also 294 
exhibited amiloride-inhibitable Isc but no response to either forskolin or GlyH-101 was 295 
observed, as expected due to the lack of CFTR in these cells (Figure 5 c, d). Thus, 296 
CFBE-BMI-1 cells, like NHBE-BMI-1, also maintain the Na+ and Cl- ion transport 297 
characteristics of non-transduced primary CF cells.   298 
Use of BMI-1 transduced cells to generate PCD cell models 299 
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We next explored the potential use of the BMI-1 transduced NHBE cells to 300 
generate an in vitro model of PCD. The outer dynein arm protein DNAH5 is the most 301 
commonly mutated gene but even so this is a rare disease and cells are often not 302 
readily available.  Cells with DNAH5 mutations lack the DNAH5 protein in the ciliary 303 
axoneme and have missing outer dynein arms (ODAs) (13). NHBE cells transduced 304 
with BMI-1 were additionally transduced with a DNAH5 shRNA lentiviral construct 305 
that also expresses green fluorescent protein (GFP). 306 
DNAH5 expression in shRNA-transduced cells was silenced by approximately 75% 307 
relative to untransduced cells (Figure 6a) while scrambled shRNA had no effect on 308 
DNAH5 expression indicating silencing specificity.  309 
NHBE-BMI-1 cells transduced with the two shRNAs were subsequently cultured at 310 
ALI to promote differentiation and ciliation. Following mucociliary differentiation, 311 
NHBE-BMI-1 GFP-positive cells, transduced with scrambled shRNA had motile cilia, 312 
(Video 2a) whereas GFP-positive DNAH5 shRNA silenced cells had immotile cilia 313 
(Video 2b). However, in GFP negative cells (and by extension also DNAH5 shRNA 314 
negative) motile cilia were still observed (Video 2c).  315 
In untransduced NHBE BMI-1 cells and those GFP-positive cells transduced with the 316 
scrambled shRNA, DNAH5 was localised to the ciliary axoneme in all ciliated cells 317 
assessed as shown by co-localisation with acetylated α-tubulin expression. In 318 
contrast, in DNAH5 shRNA transduced GFP-positive cells, only 2.9% (5/173) of 319 
ciliated cells had DNAH5 in the ciliary axoneme (Figure 6b and Table 5).   320 
 321 
  322 
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DISCUSSION  323 
Airway diseases are a significant cause of morbidity and mortality. Mucociliary 324 
differentiation of primary airway epithelial cells using ALI culture methods provides 325 
an in vitro model that faithfully recapitulates the in vivo airway epithelium for the 326 
study of disease pathology and therapies. However, these cells can only be cultured 327 
for 2-3 passages before they lose their ability to differentiate(5).  This has important 328 
practical, ethical and cost implications for research in the field. Traditional cell 329 
transformation methods, using viral oncogenes that promote entry into the cell cycle, 330 
produce immortal cell lines incapable of mucociliary differentiation most likely due to 331 
their inability to suspend cell division and allow cilia production and differentiation.  332 
We have shown that prevention of cellular senescence by expression of BMI-1 333 
allows extended passaging of HBE cells from CF and non-CF donors. Western blot 334 
analysis highlighted that senescent primary NHBE cells had accumulated high levels 335 
of the pro-senescent protein p16Ink4a in agreement with other studies (1, 6, 20). BMI-336 
1 transduced cells, however, showed low levels of p16Ink4a thereby delaying cell 337 
senescence as reported previously(15).   338 
In addition to exhibiting delayed senescence, BMI-1 transduced cells retained their 339 
cell phenotype, karyotype, ion transport characteristics and mucociliary 340 
differentiation potential with abundant ciliation observed when cultured at ALI. Ussing 341 
chamber studies revealed that, like primary HBE cells, BMI-1 transduced NHBE and 342 
CFBE cells formed electrically resistive cultures and the direction of change in Isc 343 
was as expected upon addition of amiloride, forskolin and the CFTR inhibitor Gly-344 
H101. We note that baseline TEER values varied between HBE donors as did the 345 
magnitude of change in Isc upon addition of amiloride, forskolin and the CFTR 346 
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inhibitor Gly-H101. Such variation has also been observed by Tosoni et al. (29) who 347 
recently demonstrated baseline TEER values ranged from 309 to 2963Ω.cm2 in ALI 348 
cultures generated from the cells of 18 healthy donors.  349 
In agreement with our findings, Torr et al(28) recently demonstrated that  350 
transduction of basal cells, from different two donors, with human BMI-1 alone 351 
extends the proliferative potential of NHBE cells whilst retaining their differentiation 352 
potential as demonstrated by immunostaining and scanning electron microscopy. 353 
Our study extends on these findings demonstrating that passaging capacity of 354 
diseased cells (CFBE) can also be extended using this method. Taken together this 355 
would suggest BMI-1 transduction of bronchial epithelial cells permits extended 356 
passaging and mucociliary differentiation independent of donor and/or disease status 357 
although further studies are needed to confirm this. 358 
BMI-1 transduction did not immortalise the HBE cells in contrast to viral antigens 359 
such as the SV40 large T-antigen used to produce the 16HBE14o- cell line(5). 360 
However, BMI transduced cells could still be differentiated at 20-25 passages 361 
representing a significant advantage of this method over use of viral antigens. Using 362 
the ALI culture protocol outlined in the current study one can routinely obtain from 6-363 
8 functional epithelial transwells in a 24-well ALI culture format per passage enabling 364 
the generation of a minimum of ~90-100 transwells from a single donor. This is 365 
significantly higher than the 10-15 epithelial transwells that can be generated with 366 
~1x106 primary bronchial epithelial cells (typical quantity obtained from commercial 367 
providers) or brushing of the nasal turbinate of a single donor(29). Furthermore, sub-368 
culturing of BMI-1 transformed cells, as opposed to seeding ALI cultures, would 369 
enable banking of early passage cells and the potential to generate exponentially 370 
more functional epithelia at each passage. 371 
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Tosoni et al. (29) recently demonstrated that ALI cultures generated from different 372 
healthy donors can yield epithelia with vastly different physiological properties and 373 
drug responses. The BMI-1 transduction protocol enables the generation of a large 374 
number of epithelia generated from donors with similar genetic backgrounds, or 375 
indeed from a single donor, allowing the study of disease pathophysiology in a 376 
manner that avoids the influence of genetic variability in cells from different donors. 377 
This highlights the potential for the development of personalised treatments using 378 
BMI-1 transduced cells. 379 
In addition, an extended passaging capacity affords the opportunity for modification 380 
of HBE cells to create new models, to better understand disease and find novel 381 
treatments. As a proof of concept, we transduced NHBE BMI-1 cells with shRNA 382 
targeted against DNAH5 in an attempt to create a model of PCD. The shRNA 383 
construct contained a GFP reporter to allow for selection of cells in which the DNAH5 384 
shRNA was expressed. Focussing on cells expressing GFP, we demonstrated loss 385 
of ciliary motility and absence of DNAH5 in the ciliary axoneme of cells transduced 386 
with the DNAH5 targeted shRNA so mimicking the phenotype seen in patient 387 
cells(13). shRNA-mediated knockdown has been previously used to model PCD in 388 
otherwise healthy primary HBE cells (10, 11, 17) but these cells were not long lived 389 
so could not be used for further study to assess, for example, protein interactions or 390 
novel treatments. Gene addition, shRNA knockdown, or genome editing of BMI-1 391 
transduced HBE cells could therefore provide a more useful tool for the study of a 392 
number of airway diseases.  393 
Recently the use of pharmacological Rho-kinase inhibition along with co-culture of 394 
HBE cells with irradiated feeder-layer fibroblasts has been described to allow 395 
indefinite passage of HBE cells whilst retaining the cells differentiation capacity when 396 
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placed at ALI (18, 27). However, studies where the mucociliary differentiation 397 
potential of CRCs have been assessed have not reported successful mucociliary 398 
differentiation beyond passage 11(2, 22, 27). Furthermore, CRC morphology and 399 
doubling times differ significantly to their parent cells with CRC cells being smaller 400 
and growing in colonies as well as showing faster proliferation rates(18, 27). 401 
Following viral transduction, BMI-1 expressing NHBE and CFBE cells are cultured 402 
exactly as non-transformed primary cells, without the need for a feeder layer, a factor 403 
that is likely to aid in the rapid uptake of this method of transformation and 404 
dissemination of the resulting cell models between laboratories and in the 405 
maintenance of cells in biobanks.  406 
In summary, here we have shown that BMI-1 transduction delays senescence in 407 
HBE cells from healthy and CF donors whilst maintaining the cells mucociliary 408 
differentiation potential. We have undertaken extensive characterisation of the 409 
differentiated cells showing normal ciliary beat frequency and ciliary ultrastructure. 410 
Ussing chamber studies with BMI-1 transformed NHBE and CFBE cells showed that 411 
these cells exhibit similar Na+ and Cl- ion transport characteristics to their respective 412 
primary cells, validating their use as models of CF. Furthermore, we have 413 
demonstrated how BMI-1- transduced cells can be engineered by further 414 
transduction with DNAH5 shRNA to recapitulate an in vitro disease model of primary 415 
ciliary dyskinesia, a valuable feature when studying rare diseases such as PCD 416 
where patient samples are difficult to obtain. 417 
 418 
  419 
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FIGURE LEGENDS 546 
Figure 1. BMI-1 maintains healthy cell morphology in 2D culture. 547 
The morphology of (a) NHBE cells at passage 1 and (b) passage 3 was observed 548 
under light microscopy and compared to NHBE BMI-1 cells after passages (c) 11, (d) 549 
17 and (e) 25. White arrows highlight elongated cells and black arrows highlight 550 
squamous cells. Scale bars are 100µm. 551 
Figure 2. Karyotype analysis of NHBE-BMI-1 cells. 552 
Karyotype of passage 23 NHBE-BMI-1 cells was undertaken by The Doctors 553 
Laboratory, London. 554 
Figure 3. Elevated p16Ink4a precedes senescence and BMI-1 functions by 555 
inhibiting p16Ink4a and retains a normal cell doubling time.   556 
(a) Western blot was used to assess levels of BMI-1 and p16Ink4A in serially 557 
passaged NHBE cells and BMI-1 transduced cells and (b) cell counting was used to 558 
determine the replication kinetics of NHBE and NHBE BMI-1 cells at varying 559 
passages. Growth curves are presented as percent of mean of day 1 cell count. Data 560 
are mean ± S.E.M. For each data point n=3 biological replicates.  561 
Figure 4. BMI-1 cells retain their mucociliary differentiation capacity.   562 
Extensively passaged BMI-1 transduced cells (passage 15) were differentiated on 563 
ALI and cilia beat frequency of (a) NHBE and (b) CFBE cells was determined using 564 
ciliaFA plugin(25) for ImageJ. Data are mean ± S.E.M; n= 4 independent ALI 565 
cultures, 5 fields videoed per culture. Immunostaining of NHBE-BMI-1 cells was used 566 
to show tight junction formation (occludin; c), mucin production (MUC5AC and 567 
MUC5B; d and e respectively), the presence of basal cells (p63+; f), widespread 568 
BMI-1 expression (BMI-1; g), and extensive ciliation (acetylated α-tubulin; h). TEM 569 
was used to determine cilia ultrastructure (i). Images are representative of 4 570 
independent ALI cultures per marker. Scale bars for c-h are 50µm and 100nm for i. 571 
Figure 5. BMI-1 cells form ALI cultures suitable for Ussing chamber studies.   572 
Representative Ussing chamber traces and changes in short-circuit current (Isc) in 573 
response to administration of amiloride (apical), forskolin (apical and basolateral) and 574 
GlyH-101 (apical) in primary and BMI-1 transduced (a and b) NHBE and (c and d) 575 
CFBE cells are shown. Data are mean ± S.E.M; n= at least 3 independent ALI 576 
cultures (see Table 4 for exact values). 577 
Figure 6. DNAH5 knockdown recapitulates PCD phenotype.   578 
(a) qRT-PCR was used to assess DNAH5 mRNA expression in NHBE-BMI-1 cells 579 
and NHBE BMI-1-transduced with lentivirus expressing either a scrambled or 580 
26 
 
DNAH5-targetting shRNA and grown in submerged 2D culture. **P<0.01; one-way 581 
ANOVA with Bonferroni’s post-test used to assess significance. Data are mean ± 582 
S.E.M. (b) Immunostaining for DNAH5 and acetylated α-tubulin was used to assess 583 
the presence or absence of DNAH5 in the ciliary axoneme of shRNA transduced and 584 
untransduced NHBE BMI-1 cells differentiated at ALI. Presence of GFP fluorescence 585 
denotes cells transduced with the GFP-shRNA construct and so expressing the 586 
shRNA. Scale bars are 20µm. Images are representative of 4 independent ALI 587 
cultures per condition.   588 
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TABLES 589 
Table 1. Primary antibodies used in this study. 590 
 591 
Name Supplier  Dilution  
WB/IF 
Anit-MUC5AC Life Technologies NA/1:100 
Anti-Acetylated α-
tubulin 
Sigma-Aldrich NA/1:500 
Anti-BMI-1 Life Technologies 1:200/1:100 
Anti-GAPDH Life Technologies 1:1000/1:500 
Anti-MUC5B Kind gift from Professor Dallas 
Swallow(23) 
NA/neat 
Anti-Occludin Invitrogen, Life Technologies NA/1:100 
Anti-p16INK4 Pharmingen, BD Biosciences 1:200/NA 
Anti-p63 Invitrogen, Life Technologies NA/1:100 
 592 
Table 2. Microtubule organisation of motile cilia. 593 
 594 
Microtubule Organisation Frequency (%)
Normal 9+2 92.05 
Central Pair Defect 0.66 
Disarranged 3.31 
Other Defect 3.97 
 595 
Table 3. Dynein arm presence in motile cilia. 596 
 597 
Dynein Arms Frequency (%) 
ODA and IDA Present 100.00 
ODA Only 0.00 
IDA Only 0.00 
ODA and IDA Absent 0.00 
 598 
  599 
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Table 4. Trans-epithelial electrical resistance (TEER) measurements. 600 
Name Passage TEER (Ω.cm2 ±S.E.M) n 
NHBE (AB053901) P1 621.0 ± 33.2 5 
NHBE (AB037501) P1 331.1 ± 105.5 3 
NHBE BMI-1 P13 1268.4 ± 78.4 4 
CFBE P2 1307.9 ± 36.6 5 
CFBE BMI-1 P17 917.6 ± 165.3 6 
 601 
 602 
Table 5. DNAH5 localisation. 603 
 604 
 Is DNAH5 located in 
ciliary axoneme? 
shRNA Target Yes No 
Untransduced 157 0 
Scrambled 147 0 
DNAH5 5 173 
 605 
 606 






